Foden’s Band is delighted to announce a new sponsorship partnership with Cheshire-based Acceler8 Clinical Research, bringing together two organisations with strong local roots and international reputations for excellence. The new partnership reflects a shared commitment to innovation and community, while providing valuable support to Foden’s Acceler8 Clinical Research is a Cheshire-based company in Knutsford with a global presence, including offices in Singapore, Australia and Canada. Ewan Campbell, CEO of Acceler8 Clinical Research, said: “At Acceler8, we believe in investing in excellence, whether that’s helping our clients accelerate the development of new medicines or supporting exceptional talent within our local community. “Foden’s Brass Band is a true Cheshire institution with an incredible heritage and an international reputation for excellence. We are proud to support the band and look forward to being part of its continued success.” Mark Wilkinson of Foden’s Band commented: “We are delighted to enter into this sponsorship partnership with Acceler8 Clinical Research. There are many parallels between our two organisations – both are proudly rooted in Cheshire while enjoying an international reach and reputation.’’ “Acceler8’s work supports pharmaceutical, biotechnology and medical device organisations in bringing life-changing treatments to people around the world. Their commitment to excellence and to supporting their local community makes them a fantastic partner for Foden’s. “We are extremely grateful to Ewan and the team at Acceler8 for their support and look forward to developing a successful and long-lasting relationship.”